<DOC>
	<DOCNO>NCT02256878</DOCNO>
	<brief_summary>The objective study evaluate clinically relevant interaction amitriptyline ( metabolite nortriptyline ) BIRT 2584 XX ( metabolite BI 610100 ) BIRT 2584 XX administer tablet formulation near steady state estimate high therapeutic dose . Pharmacokinetics ( PK ) amitriptyline nortriptyline measure dose BIRT 2584 XX , first dose BIRT 2584 XX , repeat dos BIRT 2584 XX near steady state</brief_summary>
	<brief_title>Study Evaluate Effect Single Multiple Oral Doses BIRT 2584 XX Tablets Pharmacokinetic Parameters Amitriptyline Nortriptyline Healthy Male Female Subjects</brief_title>
	<detailed_description />
	<mesh_term>Amitriptyline</mesh_term>
	<mesh_term>Nortriptyline</mesh_term>
	<mesh_term>Amitriptyline , perphenazine drug combination</mesh_term>
	<criteria>Healthy female male volunteer determine result screen base upon complete medical history , include physical examination , measurement vital sign ( Blood Pressure ( BP ) , Pulse Rate ( PR ) ) , 12lead ECG , clinical laboratory test Age ≥ 18 ≤ 55 year BMI ≥ 18.5 ≤ 29.9 kg/m2 ( body mass index ) Signed date write informed consent prior admission study accordance Good Clinical Practice ( GCP ) local legislation Any finding medical examination ( include BP , PR , ECG ) deviate normal clinical relevance Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunologic , hematologic , oncologic hormonal disorder Surgery gastrointestinal tract ( except appendectomy ) Diseases Central Nervous System ( CNS ) ( epilepsy ) psychiatric disorder neurological disorder Relevant history orthostatic hypotension , faint spell blackouts Chronic relevant acute infection History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator Intake drug long halflife ( &gt; 24 h ) within 1 month prior administration study drug trial Use drug might influence result trial within 10 day prior study drug administration expect trial Participation another trial investigational drug within 2 month prior administration expect trial Smoker ( &gt; 10 cigarette &gt; 3 cigar &gt; 3 pipes/day ) ; inability abstain smoke within 5 day first drug administration completion trial Alcohol abuse ( &gt; 60 g/day ) Drug abuse Blood donation loss &gt; 400 mL , within 1 month prior study drug administration expect trial Clinically relevant laboratory abnormality For male subject : Male subject whose sexual partner currently use adequate method contraception would prospectively maintain study , exclude Male subject willing use condom exclude For female subject : Pregnancy Positive pregnancy test No highly safe method contraception woman childbearing potential ( context , sterilization male partner sterilization consider highly safe method contraception ) . Hormonal contraceptive consider adequate due possible drug interaction BIRT 2584 XX Lactation period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>